CURRICULUM
VITAE
Univ. Prof. Dr. med. Hendrik Treede Leitender Oberarzt des Universitären Herzzentrums Hamburg Universitäres Herzzentrum Hamburg GmbH Klinik u. Poliklinik für Herz- u. Gefäßchirurgie Universitätsklinikum Hamburg-Eppendorf Martinistraße 52 20246 Hamburg Tel.: 040-74105-8949 Fax: 040-74105-7626 E-mail:
[email protected] Privat: Butenfeld 48 22529 Hamburg Tel.: 0152 2281 6292
Prof. Dr. med. Hendrik Treede
Persönliche Daten Prof. Dr. med. Hendrik Treede Geboren am 9. Juni 1969 in Elmshorn Verheiratet mit Dr. Martina Treede, 2 Kinder: Lennard (12J) und Corvin (8J)
Studium 1990 - 1997
Humanmedizin, Universität Hamburg
09/1995 – 10/1995
Clerkship am Massachussets General Hospital, Department of Plastic and Reconstructive Surgery (Prof. May) Harvard Medical School, Boston, MA, USA
07/1995 – 08/1995
Clerkship am Brigham and Women´s Hospital, Department of Thoracic Surgery (Prof. Sugarbaker) Harvard Medical School, Boston, MA, USA
Zivildienst 1988 - 1990
Schwerpunktkrankenhaus Elmshorn Intensivstation
Schule 1979 - 1988
Elsa-Brändström-Gymna sium, Elmshorn Abschluss: Allgemeine Hochschulreife
1975 - 1979
Grundschule Kaltenweide, Elmshorn
Berufspraxis Seit 04/2007
Leitender Oberarzt am Universitären Herzzentrum Hamburg, (Direktor Prof. Dr. H. Reichenspurner, PhD)
01/2007
Leiter des Programms für Minimal Invasive Herzchirurgie Chirurgischer Leiter Transkatheter Herzklappentherapie Chirurgischer Leiter des Programms für Schrittmacher / ICD Therapie und Laser-Sondenextraktion Personaloberarzt Leiter des Programms Lungentransplantation 2005-2010
Gebietsanerkennung “Facharzt für Herzchirurgie”
1
Prof. Dr. med. Hendrik Treede
07/2001 – 02/2007
Assistent an der Herzchirurgischen Klinik, Universitäres Herzzentrum, Hamburg
1997 - 2001
AiP und Assistent an der Herzchirurgischen Klinik, Universitätsklinikum Groß hadern, München
06/1999
Voll-Approbation als Arzt
Promotion / Habilitation / Professur 2005
Promotion mit “magna cum laude” “Der Einfluss der k ontinuierlichen veno-venösen Hämofiltration auf die Entwick lung und den Verlauf der experimentell induzierten, hämorrhagisch-nek rotisierenden Pank reatitis am Schweinemodell” Klinik für Allgemeinchirurgie Universitätsklinikum Hamburg -Eppendorf unter der Leitung von Prof. Dr. Dr. h.c. Jakob Izbicki Betreuer: Prof. Dr. med. Emre Yekebas
2012
Habilitation und Erteilung der venia legendi für das Fach Herzchirurgie Transcatheter Aortic Valve Implantation (TAVI) : Evaluation einer neuen Therapie zur minimal invasiven k athetergestützten Aortenk lappenimplantation bei Patienten mit hohem OP-Risik o oder Kontraindik ationen zur chirurgischen Therapie an der Universität Hamburg
2014
W2 Professur für Minimal Invasive und Interventionelle Herzchirurgie Medizinische Fakultät der Universität Hamburg Universitäres Herzzentrum Hamburg
Hamburg, den 20.06.2015
2
Prof. Dr. med. Hendrik Treede
Überregionale Tätigkeiten Mitgliedschaften in Fachgesellschaften Deutsche Gesellschaft für Thorax- Herz- und Gefäßchirurgie
DGTHG
European Association for Cardiothoracic Surgery
EACTS
Deutsche Gesellschaft für Kardiologie
DGK
European Society for Cardiology
ESC
International Society for Minimally Invasive Cardiac Surgery
ISMICS
International Society for Heart and Lung Transplantation
ISHLT
Editorial Board Mitherausgeber und Leiter der Rubrik „Karriere und Perspektiven“ der Zeitschrift für Herz-, Thorax- und Gefäßchirurgie (Springer Verlag)
Kommissions- / Vorstandstätigkeiten Mitglied des Vorstands der Deutschen Gesellschaft für Thorax -, Herz- und Gefäßchirurgie Mitglied der Working Group New Technologies der EACTS Mitglied der Kommission für endovaskuläre Therapien der Deutschen Gesellschaft für Thorax-, Herz- und Gefäßchirurgie (DGTHG)
Faculty / Program-Committee ISMICS Conference Program Director
2015
EACTS Annual Conference und Techno College
2013 - 2015
TCT conferences
2011 - 2015
EuroPCR conferences
2011 - 2015
ISMICS conferences
2012 - 2015
TVT conferences
2011 - 2015
3
Prof. Dr. med. Hendrik Treede
Abstract Gutachter DGTHG, DGK, ISMICS, EACTS, EuroPCR, TVT
Proctor und Clinical Instructor Laser-Sondenextraktion
(Deutsches Schulungszentrum)
TAVI TF und TA
(Symetis, Medtronic, JenaValve, Biovalve)
Minimal Invasive Mitralklappenrekonstruktion
(Fehling Surgical Instruments)
4
Prof. Dr. med. Hendrik Treede
SCHRIFTENVERZEICHNIS Originalarbeiten
121.
Treede H, Lubos E, Conradi L, Deuschl F, Asch FM, Weissman NJ, Schofer N, Schirmer J, Koschyk D, Blankenberg S, Reichenspurner H, Schaefer U. Thirty-day VARC-2 and performance data of a new self-expanding transcatheter aortic heart valve. EuroIntervention. 2015 May 20;11(1). pii: 20150410-05. doi: 10.4244/EIJY15M05_05. [Epub ahead of print]
120.
Schymik G, Lefèvre T, Bartorelli AL, Rubino P, Treede H, Walther T, Baumgartner H, Windecker S, Wendler O, Urban P, Mandinov L, Thomas M, Vahanian A. European Experience With the Second-Generation Edwards SAPIEN XT Transcatheter Heart Valve in Patients With Severe Aortic Stenosis: 1-Year Outcomes From the SOURCE XT Registry. JACC Cardiovasc Interv. 2015 Apr 27;8(5):657-69.
119.
Conradi L, Lubos E, Treede H, Pietzsch JB, Weber S, Pietzsch M, Overlack K, Diemert P, Blankenberg S, Reichenspurner H. Evolution of mitral valve procedural volumes in the advent of endovascular treatment options: Experience at an early-adopting center in Germany. Catheter Cardiovasc Interv. 2015 Apr 28.
118.
Conradi L, Schaefer A, Seiffert M, Schirmer J, Schaefer U, Schön G, Blankenberg S, Reichenspurner H, Treede H, Diemert P. Transfemoral TAVI without pre-dilatation using balloon-expandable devices: a casematched analysis. Clin Res Cardiol. 2015 Mar 1. [Epub ahead of print]
117.
Vogel B, Heinemann A, Gulbins H, Treede H, Reichenspurner H, Püschel K, Vogel H. Post-mortem computed tomography and post-mortem computed tomography angiography following transcatheter aortic valve implantation† Eur J Cardiothorac Surg. 2015 Feb 16. pii: ezv020. [Epub ahead of print]
116.
Marggraf O, Schneppenheim S, Daubmann A, Budde U, Seiffert M, Reichenspurner H, Treede H, Blankenberg S, Diemert P. Correction of acquired von Willebrand syndrome by transcatheter aortic valve implantation. Eur J Cardiothorac Surg. 2015 Feb 16. pii: ezv020. [Epub ahead of print]
5
Prof. Dr. med. Hendrik Treede 115.
Webb J, Gerosa G, Lefèvre T, Leipsic J, Spence M, Thomas M, Thielmann M, Treede H, Wendler O, Walther T. Multicenter evaluation of a next-generation balloon-expandable transcatheter aortic valve. J Am Coll Cardiol. 2014 Dec 2;64(21):2235-43.
114.
Borger MA, Moustafine V, Conradi L, Knosalla C, Richter M, Merk DR, Doenst T, Hammerschmidt R, Treede H, Dohmen P, Strauch JT. A randomized multicenter trial of minimally invasive rapid deployment versus conventional full sternotomy aortic valve replacement. Ann Thorac Surg. 2015 Jan;99(1):17-25.
113.
Kempfert J, Holzhey D, Hofmann S, Girdauskas E, Treede H, Schröfel H, Thielmann M, Walther T. First registry results from the newly approved ACURATE TA™ TAVI system† Eur J Cardiothorac Surg. 2014 Nov 25. pii: ezu367. [Epub ahead of print]
112.
Schaefer A, Treede H, Bernhardt A, Wagner FM, Reichenspurner H, Deuse T. Concomitant minimally invasive HVAD and transapical aortic valve implantation. ASAIO J. 2015 Mar-Apr;61(2):209-12.
111.
Petzoldt M, Riedel C, Braeunig J, Haas S, Goepfert MS, Treede H, Baldus S, Goetz AE, Reuter DA. Dynamic device properties of pulse contour cardiac output during transcatheter aortic valve implantation. J Clin Monit Comput. 2015 Jun;29(3):323-31.
110.
Seiffert M, Conradi L, Terstesse AC, Koschyk D, Schirmer J, Schnabel RB, Wilde S, Ojeda FM, Reichenspurner H, Blankenberg S, Schäfer U, Treede H, Diemert P. Blood transfusion is associated with impaired outcome after transcatheter aortic valve implantation. Catheter Cardiovasc Interv. 2015 Feb 15;85(3):460-7.
109.
Piazza N, Bolling S, Moat N, Treede H. Medtronic transcatheter mitral valve replacement. EuroIntervention. 2014 Sep;10 Suppl U:U112-4.
108.
Silaschi M, Conradi L, Seiffert M, Schnabel R, Schön G, Blankenberg S, Reichenspurner H, Diemert P, Treede H. Predicting Risk in Transcatheter Aortic Valve Implantation: Comparative Analysis of EuroSCORE II and Established Risk Stratification Tools. Thorac Cardiovasc Surg. 2014 Sep 5. [Epub ahead of print]
107.
Seiffert M, Bader R, Kappert U, Rastan A, Krapf S, Bleiziffer S, Hofmann S, Arnold M, Kallenbach K, Conradi L, Schlingloff F, Wilbring M, Schäfer U, Diemert P, Treede H. Initial German experience with transapical implantation of a second-generation transcatheter heart valve for the treatment of aortic regurgitation. JACC Cardiovasc Interv. 2014 Oct;7(10):1168-74.
6
Prof. Dr. med. Hendrik Treede 106.
Glanville AR, Aboyoun C, Klepetko W, Reichenspurner H, Treede H, Verschuuren EA, Boehler A, Benden C, Hopkins P, Corris PA; European and Australian Investigators in Lung Transplantation. Three-year results of an investigator-driven multicenter, international, randomized open-label de novo trial to prevent BOS after lung transplantation. J Heart Lung Transplant. 2015 Jan;34(1):16-25.
105.
Dvir D, Webb JG, Bleiziffer S, Pasic M, Waksman R, Kodali S, Barbanti M, Latib A, Schaefer U, Rodés-Cabau J, Treede H, Piazza N, Hildick-Smith D, Himbert D, Walther T, Hengstenberg C, Nissen H, Bekeredjian R, Presbitero P, Ferrari E, Segev A, de Weger A, Windecker S, Moat NE, Napodano M, Wilbring M, Cerillo AG, Brecker S, Tchetche D, Lefèvre T, De Marco F, Fiorina C, Petronio AS, Teles RC, Testa L, Laborde JC, Leon MB, Kornowski R; Valve-in-Valve International Data Registry Investigators. Transcatheter aortic valve implantation in failed bioprosthetic surgical valves. JAMA. 2014 Jul;312(2):162-70.
104.
Schnabel RB, Seiffert M, Wilde S, Schirmer J, Koschyk DH, Conradi L, Ojeda F, Baldus S, Reichenspurner H, Blankenberg S, Treede H, Diemert P Kidney injury and mortality after transcatheter aortic valve implantation in a routine clinical cohort. Catheter Cardiovasc Interv. 2015 Feb 15;85(3):440-7.
103.
Conradi L, Seiffert M, Shimamura K, Schirmer J, Blankenberg S, Reichenspurner H, Diemert P, Treede H. Successful use of a left ventricular apical access and closure device for secondgeneration transapical aortic valve implantation. Thorac Cardiovasc Surg. 2014 Sep;62(6):498-502.
102.
Diemert P, Seiffert M, Frerker C, Thielsen T, Kreidel F, Bader R, Schirmer J, Conradi L, Koschyk D, Schnabel R, Reichenspurner H, Blankenberg S, Kuck KH, Treede H, Schaefer U. Valve-in-valve implantation of a novel and small self-expandable transcatheter heart valve in degenerated small surgical bioprostheses: the Hamburg experience. Catheter Cardiovasc Interv. 2014 Sep 1;84(3):486-93.
101.
Conradi L, Kloth B, Seiffert M, Schirmer J, Koschyk D, Blankenberg S, Reichenspurner H, Diemert P, Treede H. The challenge of valve-in-valve procedures in degenerated Mitroflow bioprostheses and the advantage of using the JenaValve transcatheter heart valve. EuroIntervention. 2014 Dec;10(8):990-4
100.
Seiffert M, Sinning JM, Meyer A, Wilde S, Conradi L, Vasa-Nicotera M, Ghanem A, Kempfert J, Hammerstingl C, Ojeda FM, Kim WK, Koschyk DH, Schirmer J, Baldus S, Grube E, Möllmann H, Reichenspurner H, Nickenig G, Blankenberg S, Diemert P, Treede H, Walther T, Werner N, Schnabel RB. Development of a risk score for outcome after transcatheter aortic valve implantation. Clin Res Cardiol. 2014 Aug;103(8):631-40.
7
Prof. Dr. med. Hendrik Treede 99.
Lubos E, Schlüter M, Vettorazzi E, Goldmann B, Lubs D, Schirmer J, Treede H, Reichenspurner H, Blankenberg S, Baldus S, Rudolph V. MitraClip therapy in surgical high-risk patients: identification of echocardiographic variables affecting acute procedural outcome. JACC Cardiovasc Interv. 2014 Apr;7(4):394-402.
98.
Diemert P, Seiffert M, Schnabel R, Wilde S, Conradi L, Schirmer J, Koschyk D, Reichenspurner H, Baldus S, Treede H, Blankenberg S. Patient gender does not affect outcome after transcatheter aortic valve implantation (TAVI). J Heart Valve Dis. 2013 Nov;22(6):789-93.
97.
Seiffert M, Conradi L, Kloth B, Koschyk D, Schirmer J, Schnabel RB, Blankenberg S, Reichenspurner H, Diemert P, Treede H.
Single-centre experience with next-generation devices for transapical aortic valve implantation. Eur J Cardiothorac Surg. 2015 Jan;47(1):39-45; discussion 45.
96.
Sündermann SH, Holzhey D, Bleiziffer S, Treede H, Jacobs S, Falk V. Second-generation transapical valves: the Medtronic Engager system. Multimed Man Cardiothorac Surg. 2014;2014:mmu001.
95.
Conradi L, Seiffert M, Schirmer J, Koschyk D, Blankenberg S, Reichenspurner H, Diemert P, Treede H. Transapical transcatheter aortic valve implantation without prior balloon aortic valvuloplasty: feasible and safe. Eur J Cardiothorac Surg. 2013 Dec 11. [Epub ahead of print] Impact Factor 2.674 (2012),
94.
Diemert P, Lange P, Greif M, Seiffert M, Conradi L, Massberg S, Blankenberg S, Reichenspurner H, Hagl C, Schmitz C, Schröfel H, Treede H, Schymik G, Kupatt C. Edwards Sapien XT valve placement as treatment option for aortic regurgitation after transfemoral CoreValve implantation: a multicenter experience. Clin Res Cardiol. 2013 Nov 20. [Epub ahead of print] Impact Factor 3.667 (2012)
93.
Hakmi S, Pecha S, Sill B, Reiter B, Willems S, Aydin MA, Yildirim Y, Reichenspurner H, Treede H. Initial experience of pacemaker and implantable cardioverter defibrillator lead extraction with the new GlideLight 80 Hz laser sheaths. Interact Cardiovasc Thorac Surg. 2014 Jan;18(1):56-60. Epub 2013 Sep 30. Impact Factor 1.232 (2011)
92.
Sündermann SH, Holzhey D, Bleiziffer S, Treede H, Falk V. Medtronic Engager™ bioprosthesis for transapical transcatheter aortic valve implantation. EuroIntervention. 2013 Sep 10;9 Suppl:S97-100. Impact Factor : 3.285 (2011)
91.
Holzhey D, Linke A, Treede H, Baldus S, Bleiziffer S, Wagner A, Börgermann J, Scholtz W, Vanoverschelde JL, Falk V.
8
Prof. Dr. med. Hendrik Treede Intermediate follow-up results from the multicenter engager European pivotal trial. Ann Thorac Surg. 2013 Dec;96(6):2095-100. Epub 2013 Sep 7. Impact Factor : 3.644 (2011) 90.
Conradi L, Treede H, Reichenspurner H. Hybrid coronary revascularization: a task for the true heart team! Eur J Cardiothorac Surg. 2013 Aug 30. [Epub ahead of print] Impact Factor : 2.550 (2011)
89.
Schirmer J, Conradi L, Seiffert M, Koschyk D, Blankenberg S, Reichenspurner H, Diemert P, Treede H. Transcatheter aortic valve implantation: alternative access options. Minerva Cardioangiol. 2013 Aug;61(4):429-35. Impact Factor: 0.427 (2011)
88.
Bernhardt AM*, Treede H*, Detter C, Rybczynski M, Sheikhzadeh S, Wagner FM, Kodolitsch YV, Reichenspurner H. *geteilte Erstautorenschaft Results of Modern Mitral Valve Repair in Patients with Marfan Syndrome. Thorac Cardiovasc Surg. 2013 Jul 9. [Epub ahead of print] Impact Factor: 3.406 (2011)
87.
Seiffert M, Diemert P, Koschyk D, Schirmer J, Conradi L, Schnabel R, Blankenberg S, Reichenspurner H, Baldus S, Treede H. Transapical implantation of a second-generation transcatheter heart valve in patients with noncalcified aortic regurgitation. JACC Cardiovasc Interv. 2013 Jun;6(6):590-7. Epub 2013 May 15. Impact Factor: 6.800(2011)
86.
Conradi L, Seiffert M, Blankenberg S, Reichenspurner H, Diemert P, Treede H. What's new in transapical aortic valve implantation: clinical experience with second generation devices. Minerva Cardioangiol. 2013 Jun;61(3):341-9. Impact Factor: 0.427 (2011)
85.
D'Ascenzo F, Conrotto F, Giordana F, Moretti C, D'Amico M, Salizzoni S, Omedè P, La Torre M, Thomas M, Khawaja Z, Hildick-Smith D, Ussia G, Barbanti M, Tamburino C, Webb J, Schnabel RB, Seiffert M, Wilde S, Treede H, Gasparetto V, Napodano M, Tarantini G, Presbitero P, Mennuni M, Rossi ML, Gasparini M, Biondi Zoccai G, Lupo M, Rinaldi M, Gaita F, Marra S. Mid-term prognostic value of coronary artery disease in patients undergoing transcatheter aortic valve implantation: A meta-analysis of adjusted observational results. Int J Cardiol. 2013 Apr 26. doi:pii: S0167-5273(13)00481-6. [Epub ahead of print] Impact Factor: 4.125 (2011)
84.
Diegeler A, Börgermann J, Kappert U, Breuer M, Böning A, Ursulescu A, Rastan A, Holzhey D, Treede H, Rieß FC, Veeckmann P, Asfoor A, Reents W, Zacher M, Hilker M; the GOPCABE Study Group Off-Pump versus On-Pump Coronary-Artery Bypass Grafting in Elderly Patients. N Engl J Med. 2013 Mar 11. [Epub ahead of print] Impact Factor: 53.298(2011)
9
Prof. Dr. med. Hendrik Treede
83.
Pecha S, Aydin MA, Yildirim Y, Sill B, Reiter B, Wilke I, Reichenspurner H, Treede H. Transcutaneous lead implantation connected to an externalized pacemaker in patients with implantable cardiac defibrillator/pacemaker infection and pacemaker dependency. Europace. 2013 Feb 20. [Epub ahead of print] Impact Factor: 1.980(2011)
82.
81.
Rudolph V, Lubos E, Schlüter M, Lubs D, Goldmann B, Knap M, de Vries T, Treede H, Schirmer J, Conradi L, Wegscheider K, Reichenspurner H, Blankenberg S, Baldus S. Aetiology of mitral regurgitation differentially affects 2-year adverse outcomes after MitraClip therapy in high-risk patients. Eur J Heart Fail. 2013 Feb 20. [Epub ahead of print] Impact Factor: 4.896 (2011) Conradi L, Treede H, Rudolph V, Graumüller P, Lubos E, Baldus S, Blankenberg S, Reichenspurner H. Surgical or percutaneous mitral valve repair for secondary mitral regurgitation: comparison of patient characteristics and clinical outcomes. Eur J Cardiothorac Surg. 2013 Feb 10. [Epub ahead of print] Impact Factor : 2.550(2011)
80.
Seiffert M, Conradi L, Baldus S, Schirmer J, Blankenberg S, Reichenspurner H, Diemert P, Treede H. Severe intraprocedural complications after transcatheter aortic valve implantation: calling for a heart team approach. Eur J Cardiothorac Surg. 2013 Feb 6. [Epub ahead of print] Impact Factor : 2.550(2011)
79.
Conradi L, Seiffert M, Treede H, Rudolph V, Silaschi M, Blankenberg S, Baldus S, Reichenspurner H. Towards an integrated approach to mitral valve disease: implementation of an interventional mitral valve programme and its impact on surgical activity. Eur J Cardiothorac Surg. 2013 Jan 25. [Epub ahead of print] Impact Factor : 2.550(2011)
78.
Walther T, Thielmann M, Kempfert J, Schroefel H, Wimmer-Greinecker G, Treede H, Wahlers T, Wendler O. One-year multicentre outcomes of transapical aortic valve implantation using the SAPIEN XT™ valve: the PREVAIL transapical study. Eur J Cardiothorac Surg. 2013 Jan 22. [Epub ahead of print] Impact Factor : 2.550(2011)
77.
Thoenes M, Treede H, Franzen O, Kirch W. Transcatheter aortic valve implantation (TAVI) for the treatment of aortic stenosis: aspects of health care research. Dtsch Med Wochenschr. 2013 Feb;138(5):218-22. Impact Factor :0.528
76.
Petzoldt M, Riedel C, Braeunig J, Haas S, Goepfert MS, Treede H, Baldus S, Goetz AE, Reuter DA. Stroke volume determination using transcardiopulmonary thermodilution and arterial pulse contour analysis in severe aortic valve disease.
10
Prof. Dr. med. Hendrik Treede Intensive Care Med. 2013 Jan 4. [Epub ahead of print] Impact Factor: 5.399 75.
Baum C, Seiffert M, Treede H, Reichenspurner H, Deuse T. Concomitant transcatheter aortic valve and left ventricular assist device implantation. ASAIO J. 2013 Jan-Feb;59(1):90-2. Impact Factor: 1.394
74.
73.
Rudolph V, Moenig C, Lubos E, Lubs D, Knap M, Schlüter M, Kuß O, Koschyk D, Schwoerer AP, Treede H, Schirmer J, Reichenspurner H, Ehmke H, Blankenberg S, Baldus S. Baseline systolic left ventricular function determines hemodynamic adaptation following percutaneous mitral valve repair. Int J Cardiol. 2012 Dec 6. S0167-5273(12)01576 Impact Factor: 7.078 (2011) Seiffert M, Schnabel R, Conradi L, Diemert P, Schirmer J, Koschyk D, Linder M, Kersten JF, Grosser A, Wilde S, Blankenberg S, Reichenspurner H, Baldus S, Treede H. Predictors and outcomes after transcatheter aortic valve implantation using different approaches according to the valve academic research consortium definitions. Catheter Cardiovasc Interv. 2012 Nov 21. [Epub ahead of print] Impact Factor: 2.398 (2011)
72.
Wendler O, Walther T, Schroefel H, Lange R, Treede H, Fusari M, Rubino P, Thomas M; SOURCE investigators. Transapical aortic valve implantation: mid-term outcome from the SOURCE registry. Eur J Cardiothorac Surg. 2013 Mar;43(3):505-11; discussion 511-2. Impact Factor: 2.550 (2011)
71.
Treede H, Glanville AR, Klepetko W, Aboyoun C, Vettorazzi E, Lama R, Bravo C, Knoop C, Aubert JD, Reichenspurner H; European and Australian Investigators in Lung Transplantation Tacrolimus and cyclosporine have differential effects on the risk of development of bronchiolitis obliterans syndrome: Results of a prospective, randomized international trial in lung transplantation. J Heart Lung Transplant. 2012 Aug;31(8):797-804. [Epub 2012 May 2]. Impact Factor: 4.332 (2011)
70.
Treede H, Rastan A, Ferrari M, Ensminger S, Figulla HR, Mohr F. Innovations/Novel Technologies: JenaValve. EuroInterv. 2012 ;8 :Q88-Q93. Impact Factor: 3.285 (2011)
69.
Treede H, Mohr FW, Baldus S, Rastan A, Ensminger S, Arnold M, Kempfert J, Figulla HR Transapical transcatheter aortic valve implantation using the JenaValve™ system: acute and 30-day results of the multicentre CE-mark study. Eur J Cardiothorac Surg. 2012 Jun;41(6):e131-8. Epub 2012 Apr 16. Impact Factor: 2.550(2011)
68.
Wendler O, Thielmann M, Schroefel H, Rastan A, Treede H, Wahlers T, Eichinger W, Walther T
11
Prof. Dr. med. Hendrik Treede Worldwide experience with the 29-mm Edwards SAPIEN XTTM transcatheter heart valve in patients with large aortic annulus. Eur J Cardiothorac Surg. 2013 Feb;43(2):371-7. [Epub 2012 Apr 20]. Impact Factor: 2.550(2011) 67.
Kempfert J, Treede H, Rastan AJ, Schönburg M, Thielmann M, Sorg S, Mohr FW, Walther T Transapical aortic valve implantation using a new self-expandable bioprosthesis (ACURATE TA™): 6-month outcomes. Eur J Cardiothorac Surg. 2013 Jan;43(1):52-6; discussion 57. Impact Factor: 2.550(2011)
66.
Rudolph V, Schirmer J, Franzen O, Schlüter M, Seiffert M, Treede H, Reichenspurner H, Blankenberg S, Baldus S Bivalvular transcatheter treatment of high-surgical-risk patients with coexisting severe aortic stenosis and significant mitral regurgitation. Int J Cardiol. 2012 Mar 27. Impact Factor: 7.078 (2011)
65.
Seiffert M, Conradi L, Baldus S, Schirmer J, Knap M, Blankenberg S, Reichenspurner H, Treede H. Transcatheter mitral valve-in-valve implantation in patients with degenerated bioprostheses. JACC Cardiovasc Interv. 2012 Mar;5(3):341-9. Impact Factor: 6.800(2011)
64.
Conradi L, Baldus S, Treede H, Seiffert M, Schirmer J, Rudolph V, Blankenberg S, Reichenspurner H The Best of Both Worlds: Staged Hybrid Approach to Complex Cardiac Disease in a Patient at High Surgical Risk. Thorac Cardiovasc Surg. 2012 Mar 1. [Epub ahead of print] Impact Factor: 3.406 (2011)
63.
Walther T, Thielmann M, Kempfert J, Schroefel H, Wimmer-Greinecker G, Treede H, Wahlers T, Wendler O PREVAIL TRANSAPICAL: multicentre trial of transcatheter aortic valve implantation using the newly designed bioprosthesis (SAPIEN-XT) and delivery system (ASCENDRA-II). Eur J Cardiothorac Surg. 2012 Aug;42(2):278-83; discussion 283. Impact Factor: 2.550 (2011)
62.
Seiffert M, Conradi L, Baldus S, Knap M, Schirmer J, Franzen O, Koschyk D, Meinertz T, Reichenspurner H, Treede H Impact of patient-prosthesis mismatch after transcatheter aortic valve-in-valve implantation in degenerated bioprostheses. J Thorac Cardiovasc Surg. 2012 Mar;143(3):617-24. [Epub 2011 Dec 9]. Impact Factor: 3.406 (2011)
61.
Kappetein AP, Head SJ, Treede H, Reichenspurner H, Mohr FW, Walther T What is the evidence allowing us to state that transcatheter aortic valve replacement via the femoral artery is a more attractive option compared to transapical valve replacement?
12
Prof. Dr. med. Hendrik Treede EuroIntervention. 2011;7(8):903-4. Impact Factor: 3.285 60.
Bijuklic K, Tuebler T, Reichenspurner H, Treede H, Wandler A, Harreld JH, Low RI, Schofer J Midterm stability and hemodynamic performance of a transfemorally implantable nonmetallic, retrievable, and repositionable aortic valve in patients with severe aortic stenosis: up to 2-year follow-up of the direct-flow medical valve: a pilot study Circ Cardiovasc Interv. 2011;4(6):595-601. Impact Factor: 6.058
59.
Eggebrecht H, Schäfer U, Treede H, Boekstegers P, Babin-Ebell J, Ferrari M, Möllmann H, Baumgartner H, Carrel T, Kahlert P, Lange P, Walther T, Erbel R, Mehta RH, Thielmann M Valve-in-valve transcatheter aortic valve implantation for degenerated bioprost hetic heart valves. JACC Cardiovasc Interv. 2011;4(11):1218-27. Impact Factor: 6.800
58.
Seiffert M, Baldus S, Conradi L, Koschyk D, Schirmer J, Meinertz T, Reichenspurner H, Treede H. Simultaneous transcatheter aortic and mitral valve-in-valve implantation in a patient with degenerated bioprostheses and high surgical risk. Thorac Cardiovasc Surg. 2011;59(8):490-2. Impact Factor: 3.406
57.
Rudolph V, Knap M, Franzen O, Schlüter M, de Vries T, Conradi L, Schirmer J, Treede H, Wegscheider K, Costard-Jäckle A, Meinertz T, Reichenspurner H, Baldus S Echocardiographic and clinical outcomes of MitraClip therapy in patients not amenable to surgery. J Am Coll Cardiol. 2011;58(21):2190-5. Impact Factor: 14.156
58.
Kölbel T, Treede H, Carpenter SW, Diener H, Larena-Avellaneda A, Debus ES. Transapical access for thoracic endograft delivery. Vascular. 2011;19(6):308-12. Impact Factor: 0.891
57.
Conradi L, Seiffert M, Treede H, Silaschi M, Baldus S, Schirmer, J, Kersten JF, Meinertz T, Reichenspurner H Transcatheter aortic valve implantation versus surgic al aortic valve replacement: A propensity score analysis in patients at high surgical risk. J Thorac Cardiovasc Surg. 2012 Jan; 143(1): 64-71. Impact Factor: 3.406 (2011)
56.
Treede H, Schrimer J, Rudolph V, Franzen O, Knap M, Schluter M, Conradi L, Seiffert M, Koschyk D, Meinertz T, Baldus S, Reichenspurner H A heart team’s perspective on interventional mitral valve repair: Percutaneous clip
13
Prof. Dr. med. Hendrik Treede implantation as an important adjunct to a surgical mitral valve program for treatment of high-risk patients. J Thorac Cardiovasc Surg. 2012; 143(1):78-84. Impact Factor: 3.406 (2011) 55.
Conradi L, Treede H, Baldus S, Seiffert M, Blankenberg S, Reichenspurner H Treating mitral regurgitation: A surgical and interventional update. Herz. 2011; 36(8):677-685. Impact Factor: 0.924
54.
Bernhardt A, Treede H, Rybzcynski M, Sheikzadeh S, Meinertz T, Reichenspurner H, von Kodolitsch Y Diagnosis and options for reconstructive heart valve surgery in the Marfan syndrome. Kardiologia. 2011; 51(8):85-90. Impact Factor: 0.204
53.
Haas S, Trepte C, Rybczynski M, Somville T, Treede H, Reuter DA Type A aortic dissection during late pregnancy in a patient with Marfan syndrome. Can J Anaesth 2011; 58(11):1024-8. Impact Factor: 2.346
52.
Aydin A, Desai N, Bernhardt AM, Treede H, Detter C, Sheikzadeh S, Rybczynski M, Hillebrand M, Lorenzen V, Mortensen K, Robinson PN, Berger J, Reichenspurner H, Meinertz T, Willems S, von Kodolitsch Y Ascending aortic aneurysm and aortic valve dysfunction in bicuspid aortic valve disease. Int J Cardiol. 2011 Jul 29. (Epub ahead of print) Impact Factor: 7.078
51.
Thomas M, Schymik G, Walther T, Himbert D, Lefèvre T, Treede H, Eggebrecht H, Rubino P, Colombo A, Lange R, Schwarz RR, Wendler O. One-Year Outcomes of Cohort 1 in the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) Registry: The European Registry of Transcatheter Aortic Valve Implantation Using the Edwards SAPIEN Valve. Circulation. 2011 Jul 26;124(4):425-33. [Epub 2011 Jul 11]. Impact Factor: 14.739
50.
Eggebrecht H, Schäfer U, Treede H, Babin-Ebell J, Baumgartner H, Carrel T, Ferrari M, Kahlert P, Möllmann H, Thielmann M, Walther T, Erbel R Valve-in-Valve Transcatheter Aortic Valve Implantation (TAVI) for Degenerated Bioprosthestic Heart Valves: Results from a Multicenter "Real-World" Experience. JACC Cardiovasc Interv. 2011 Nov;4(11):1218-27. Impact Factor: 6.800
49.
Seiffert M, Baldus S, Conradi L, Schirmer J, Meinertz T, Reichenspurner H, Treede H. Transcatheter Aortic and Mitral Valve-in-Valve Implantations in a Single Procedure in Patients with Degenerated Bioprostheses and High Surgical Risk
14
Prof. Dr. med. Hendrik Treede Thorac Cardiovasc Surg. 2011 Dec;59(8):490-2. [Epub 2011 Nov 11]. Impact Factor: 3.406 48.
Haas S, Trepte C, Rybczynski M, Somville T, Treede H, Reuter D. A Type A aortic dissection during late pregnancy in a patient with Marfan syndrome. Can J Anaesth. 2011 Nov;58(11):1024-8. [Epub 2011 Aug 6]. Impact Factor: 2.346
47.
Conradi L, Treede H, Franzen O, Seiffert M, Baldus S, Schirmer J, Meinertz T, Reichenspurner H. Impact of MitraClip™ therapy on secondary mitral valve surgery in patients at high surgical risk. Eur J Cardiothorac Surg. 2011 Dec;40(6):1521-6. [Epub 2011 Apr 15]. Impact Factor: 2.550
46.
Bernhardt AM, Treede H, Rybczynski M, Sheikzadeh S, Kersten JF, Meinertz T, von Kodolitsch Y, Reichenspurner H. Comparison of aortic root replacement in patients with Marfan syndrome. Eur J Cardiothorac Surg. 2011 Nov;40(5):1052-7. [Epub 2011 Mar 23]. Impact Factor: 2.550
45.
Franzen O, Seiffert M, Baldus S, Conradi L, Sc hirmer J, Kubik M, Meinertz T, Reichenspurner H, Treede H. Percutaneous mitral valve repair as a bail-out strategy for patients with severe mitral regurgitation after cardiac surgery. J Thorac Cardiovasc Surg. 2011 Jul;142(1):227-30. Epub 2011 Jan 17. Impact Factor: 3.406
44.
Rybczynski M*, Treede H*, Sheikzadeh S, Groene EF, Bernhard AMJ, Hillebrand M, Mir T, Kühne K, Koschyk D, Robinson PN, Berger J, Reichenspurner H, Meinertz T, von Kodolitsch Y. Predictors of Outcome of Mitral Valve Prolapse in Patients with the Marfan S yndrome Am J Cardiol 2011 Jan 15;107(2):268-74 Impact Factor: 3.368
43.
Wendler O, Walther T, Schroefel H, Lange R, Treede H, Fusari M, Rubino F, Thomas M The SOURCE-Registry: What Is The Learning Curve In Transapical Aortic Valve Implantation? Eur J Cardiothorac Surg. 2011 Jun;39(6):853-60. [Epub 2010 Dec 22]. Impact Factor: 2.550
42.
Conradi L, Deuse T, Treede H, Seiffert M, Adam M, Costard-Jaeckle A, Wagner FM, Reichenspurner H Minimally-invasive resection of a right atrial mass in a cardiac transplant recipient Transplant Proc. 2011 June;43:2059–2062. Impact Factor: 1.005
15
Prof. Dr. med. Hendrik Treede 41.
Seiffert M, Meyer S, Franzen O, Arunagirinathan U, Conradi L, Schirmer J, Deuse T, Wagner FM, Costard-Jaeckle A, Baldus S, Reichenspurner H, Treede H Transcatheter Aortic Valve Implantation in a Heart Transplant Recipient Transplant Proc. 2010 Dec;42(10):4661-3. Impact Factor: 0.993
40.
Conradi L, Seiffert M, Franzen O, Baldus S, Schirmer J, Meinertz T, Reichenspurner H, Treede H. First experience with transcatheter aortic valve implantation and concomitant percutaneous coronary intervention. Clin Res Cardiol. 2011 Apr;100(4):311-6. [Epub 2010 Oct 21]. Impact Factor: 2.961
39.
Rybczynski M, Mir T, Sheikzadeh S, Bernhard AMJ, Schad C, Treede H, Veldhoen S, Groene EF, Kühne K, Koschyk D, Robinson PN, Berger J, Reichenspurner H, Meinertz T, von Kodolitsch Y Frequency and Age-Related Course of Mitral Valve Dysfunction in the Marfan Syndrome. Am J Cardiol 2010;106(7):1048 –1053. Impact Factor: 3.601
38.
Kölbel T, Rostock T, Larena-Avellaneda A, Treede H, Franzen O, Debus ES Externalized Transseptal Guidewire to Facilitate Passage and Guidewire-Stabilization in the Aortic Arch. J Endovac Ther 2010;17(6):744–749. Impact Factor: 2.942
37.
Manow ML, Rybczynski M, Paulsen N, Mir T, Bernhardt AMJ, Treede H, Ohm G, Fuisting B, Rehder U, Meier F, Vogler M, Meinertz T, Overlack K, von Kodolitsch Y Analyse der Erlössituation bei der ambulanten Behandlung nach § 116 b SGB V am Beispiel des Marfan-Syndroms. [Analysis of costs and profits of ambulatory care of Marfan patients after initiation of a novel German legal directive (116b SGB V)] Med Klin (Munich). 2010 Aug;105(8):529-37. Impact Factor: 0.447
36.
Conradi L, Schirmer J, Reiter B, Treede H, Kubik M, Reichenspurner H, Wagner FM First Successful Use of the New AB5000 Portable Circulatory Support Console as Bridge to Recovery in a Case of Dilated Cardiomyopathy Int J Artif Organs. 2010 Dec; 33(11):824-827. Impact Factor: 1.503
35.
Seiffert M, Franzen O, Schirmer J, Baldus S, Conradi L, Reichenspurner H, Meinertz T, Treede H. Series of transcatheter valve-in-valve implantations in high-risk patients with degenerated bioprostheses in aortic and mitral position. Catheter Cardiovasc Interv. 2010 Oct 1;76(4):608-15. Impact Factor: 2.398
34.
Thomas M, Schymik G, Walther T, Himbert D, Lefèvre T, Treede H, Eggebrecht H, Rubino P, Michev I, Lange R, Anderson WN, Wendler O
16
Prof. Dr. med. Hendrik Treede 30 Days Results of the SOURCE Registry: A European Registry of Transcatheter Aortic Valve Implantation using the Edwards SAPIENTM Valve Circulation. 2010 Jul 6;122(1):62-9. Epub 2010 Jun 21. Impact Factor: 14.432 33.
Conradi L, Treede H, Reichenspurner H. Interventional rescue strategy after malpositioning of a percutaneous aortic valve. Heart. 2010 Mar;96(5):407. Impact Factor: 4.708
32.
Treede H, Conradi L, Reichenspurner H. Chirurgische Therapie der Mitralinsuffizienz: Wann, wen, wie? Der Kardiologe. 2010; April 4(2):163-172. Impact Factor: 0.342
31.
Mortensen K, Baulmann J, Rybcynski M, Sheikzadeh S, Aydin MA, Dombrowski E, Kühne K, Peitsmeier P, Treede H, Habermann C, Robinson P, Stuhrmann M, Berger J, Meinertz T, von Kodolitsch Y. Augmentation index and the evolution of aortic disease in Marfan-like syndromes Am J Hypertension. 2010; 23(7):716-24. Impact Factor: 3.129
30.
Rybczynski M, Koschyk D, Karmeier A, Gessler N, Sheikhzadeh S, Bernhardt AMJ, Habermann C, Treede H, Berger J, Robinson P, Meinertz T, von Kodolitsch Y. Sleep Apnoea Relates to Cardiovascular Disease in Adults with Marfan Syndrome Am J Cardiol. 2010; 105:1836-1841. Impact Factor: 3.601
29.
Wendler O, Walther T, Nataf P, Rubino P, Schroefel H, Thielmann M, Treede H, Thomas M Trans-apical aortic valve implantation: univariate and multivariate analys es of the early results from the SOURCE registry Eur J Cardio-Thoracic Surg. 2010 Aug;38(2):119-27. Impact Factor: 2.293
28.
Rudolph V, Andrié R, Rudolph T, Friedrichs K, Klinke A, Hirsch-Hoffmann B, Schwoerer A, Lau D, Fu XM, Klingel K, Sydow K, Didié M, von Leitner E, Szoecs K, Schrickel J, Treede H, Wenzel U, Lewalter T, Nickenig G, Zimmermann W, Meinertz T, Böger R, Reichenspurner H, Freeman B, Ehmke H, Hazen S, Willems S, Baldus S. Myeloperoxidase, a key mediator of atrial fibrillation Nature Medicine 2010; 16(4):470-4. Impact Factor: 25.430
27.
von Kodolitsch Y, Rybczynski M, Bernhardt A, Mir T, Treede H, Dodge-Khatami A, Robinson P, Sheikhzadeh S, Reichenspurner H, Meinertz T Marfan Syndrome and the Evolving Spectrum of Heritable Thoracic Aortic Disease: Do We Need Genetics for clinical decisions? VASA. 2010; 39: 17-32. Impact Factor:1.508
17
Prof. Dr. med. Hendrik Treede
26.
Franzen O, Baldus S, Rudolph V, Meyer S, Knap M, Koschyk D, Treede H, Barmeyer A, Schofer J, Costard-Jaeckle A, Reichenspurner H, Meinertz T. Acute outcomes of MitraClip therapy for mitral regurgitation in high-surgical-risk patients: emphasis on adverse valve morphology and severe left ventricular dysfunction Eur Heart J. 2010; 31(11):1373-81. Impact Factor: 10.478
25.
Treede H, Tübler T, Reichenspurner H, Grube E, Pascotto A, Franzen O, Mueller R, Low R, Bolling S, Meinertz T, Schofer J Six Months Results of a Repositionable and Retrievable Pericardial Valve for Transcatheter Aortic Valve Replacement: The Direct Flow Medical Percutaneous Aortic Valve J Thorac Cardiovasc Surg. 2010 Oct;140(4):897-903. Impact Factor: 3.608
24.
von Kodolitsch, Aydin MA, Berhardt AMJ, Habermann C, Treede H, Reichenspurner H, Meinertz T and Dodge-Khatami A Aortic aneurysms after correction of aortic coarctation: A systematic review. VASA. 2010; 39: 3-16. Impact Factor:1.508
23.
Conradi L, Treede H, Reichenspurner H. Innovative Techniken in der modernen Aortenklappenchirurgie Clin Res Cardiol Suppl. 2009; 4:108-117. Impact Factor:2.958
22.
Conradi L, Schofer J, Franzen O, Treede H, Baldus S, Tübler T, Pascotto A, Reichenspurner H, Meinertz T. Herzklappenerkrankungen - Neue Strategien zur Therapie - Erfahrungen mit mehr als 180 Herzklappen-Interventionen am Universitären Herzzentrum des UKE Hamburg Hamburger Ärzteblatt 2009;10:22-25.
21.
Conradi L, Treede H, Brickwedel J, Reichenspurner H Use of initial biventricular mechanical support in a case of pos tinfarction ventricular septal rupture as a bridge to surgery. Ann Thorac Surg. 2009 May;87(5):e37-9. Impact Factor: 3.644
20.
Schofer J, Schlüter M, Treede H, Franzen O, Tübler T, Pascotto A, Low R, Bolling SF, Meinertz T, Reichenspurner H. Retrograde Transarterial Implantation of a Nonmetallic Aortic Valve Prosthesis in High– Surgical-Risk Patients with Severe Aortic Stenosis: A First-in-Man Feasibility and Safety Study Circulation: Cardiovascular Interventions. 2008;1:126-133. Impact Factor: 14.595
18
Prof. Dr. med. Hendrik Treede
19.
Conradi L, Treede H, Reichenspurner H Moderne Mitral- und Trikuspidalklappenchirurgie Clin Res Cardiol Suppl. 2008; 3:41-47. Impact Factor: 2.418
18.
Chalajour F, Treede H, Gehling UM, Ebrahimnejad A, Boehm DH, Riemer RK, Ergun S, Reichenspurner H. Identification and characterization of cells with high angiogenic potential and transitional phenotype in calcific aortic valve. Exp Cell Res. 2007 Jul 1;313(11):2326-35. Impact Factor: 3.695
17.
Grimm M, Mahnecke N, Soja F, El-Armouche A, Haas P, Treede H, Reichenspurner H, Eschenhagen T. The MLCK-mediated alpha1-adrenergic inotropic effect in atrial myocardium is negatively modulated by PKCepsilon signaling. Br J Pharmacol. 2006 Aug;148(7):991-1000. Impact Factor: 3.825
16.
Zengin E, Chalajour F, Gehling UM, Ito WD, Treede H, Lauke H, Weil J, Reichenspurner H, Kilic N, Ergun S. Vascular wall resident progenitor cells: a source for postnatal vasculogenesis. Development. 2006 Apr;133(8):1543-51. Impact Factor:7.764
15.
Reichenspurner H, Detter C, Deuse T, Boehm DH, Treede H, Reichart B. Video and robotic-assisted minimally invasive mitral valve surgery: a comparison of the Port-Access and transthoracic clamp techniques. Ann Thorac Surg. 2005 Feb;79(2):485-90; discussion 490-1. Impact Factor: 2.229
14.
Chalajour F, Treede H, Ebrahimnejad A, Lauke H, Reichenspurner H, Ergun S. Angiogenic activation of valvular endothelial cells in aortic valve stenosis. Exp Cell Res. 2004 Aug 15;298(2):455-64. Impact Factor: 4.007
13.
Schrepfer S, Deuse T, Detter C, Treede H, Koops A, Boehm DH, Willems S, LacourGayet F, Reichenspurner H. Successful resection of a symptomatic right ventricular lipoma. Ann Thorac Surg. 2003 Oct;76(4):1305-7. Impact Factor: 2.041
12.
Zuckermann A, Reichenspurner H, Birsan T, Treede H, Deviatko E, Reichart B, Klepetko W. Cyclosporine A versus tacrolimus in combination with mycophenolate mofetil and steroids as primary immunosuppression after lung transplantation: one-year results of a 2-center prospective randomized trial.
19
Prof. Dr. med. Hendrik Treede
11.
10.
J Thorac Cardiovasc Surg. 2003 Apr;125(4):891-900. Impact Factor: 0.872 Becker CR, Knez A, Leber A, Treede H, Ohnesorge B, Schoepf UJ, Reiser MF. Detection of coronary artery stenoses with multislice helical CT angiography. J Comput Assist Tomogr. 2002 Sep-Oct;26(5):750-5. Impact Factor: 1.354 Treede H, Becker C, Reichenspurner H, Knez A, Detter C, Reiser M, Reichart B. Multidetector computed tomography (MDCT) in coronary surgery: first experiences with a new tool for diagnosis of coronary artery disease. Ann Thorac Surg. 2002 Oct;74(4):S1398-402. Impact Factor: 2.052
9.
Becker CR, Knez A, Leber A, Treede H, Haberl R, Reiser MF. Angiography with multi-slice spiral CT. Detecting plaque, before it causes symptoms MMW Fortschr Med. 2001 Apr 19;143(16):30-2.
8.
Treede H, Klepetko W, Reichenspurner H, Zuckermann A, Meiser B, Birsan T, Wisser W, Reichart B; Munich and Vienna Lung Transplant Group. Tacrolimus versus cyclosporine after lung transplantation: a prospective, open, randomized two-center trial comparing two different immunosuppressive protocols. J Heart Lung Transplant. 2001 May;20(5):511-7. Impact Factor:2.179
7.
Treede H, Reichenspurner H, Meiser BM, Kur F, Furst H, Vogelmeier C, Briegel J, Reichart B. Incidence and spectrum of infections in lung transplanted patients: comparison of four different immunosuppressive protocols. Transplant Proc. 2001 Feb-Mar;33(1-2):1620-1. Impact Factor: 0.568
6.
Treede H, Reichenspurner H, Meiser B, Schenk S, Kur F, Furst H, Vogelmeier C, Briegel J, Reichart B. Influence of four different immunosuppressive protocols on acute and chronic rejection (BOS) after lung transplantation - experiences in 120 patients. J Heart Lung Transplant. 2001 Feb;20(2):176. Impact Factor: 2.179
5.
Yekebas E, Treede H, Jochum M, Gippner-Steppert C, Bloechle C, Knoefel WT, Scholz J, Fink E, Izbicki JR. Bradykinin B2-receptor antagonism attenuates fatal cardiocirculatory breakdown induced by severe experimental pancreatitis. Crit Care Med. 2000 Apr;28(4):1119-27. Impact Factor:3.824
4.
Becker CR, Knez A, Leber A, Hong C, Treede H, Wildhirt S, Ohnesorge B, Flohr T, Schoepf UJ, Reiser MF. Erste Erfahrungen mit der Mehrzeilendetektorspiral-CT in der Diagnostik der Arteriosklerose der Koronargefäße Der Radiologe. 2000 Feb;40(2):118-22.
20
Prof. Dr. med. Hendrik Treede Impact Factor:0.608 3.
Reichenspurner H, Kur F, Treede H, Meiser BM, Deutsch O, Welz A, Vogelmeier C, Schwaiblmair M, Muller C, Furst H, Briegel J, Reichart B. Optimization of the immunosuppressive protocol after lung transplantation. Transplantation. 1999 Jul 15;68(1):67-71. Impact Factor: 3.463
2.
Yekebas EF, Treede H, Knoefel WT, Bloechle C, Fink E, Izbicki JR. Influence of zero-balanced hemofiltration on the course of severe experimental pancreatitis in pigs. Ann Surg. 1999 Apr;229(4):514-22. Impact Factor: 5.647
1.
Reichenspurner H, Kur F, Treede H, Meiser BM, Welz A, Vogelmeier C, Schwaiblmeier M, Muller C, Furst H, Briegel J, Reichart B. Tacrolimus-based immunosuppressive protocols in lung transplantation. Transplant Proc. 1999 Feb-Mar;31(1-2):171-2. Impact Factor: 0.590
21
Prof. Dr. med. Hendrik Treede
Buchbeiträge
7.
From minimally invasive to percutaneous aortic valve replacement Aortic Root Surgery Edited by Yankah C, Weng Y, Hetzer R Kap. 8, 2010;46-56. 2009 L. Conradi, H. Treede and H. Reichenspurner
6.
Was gibt es Neues in der Chirurgie, Jahresband 2007 (What’s new in Surgery) Berichte zur chirurgischen Fort- und Weiterbildung Editors: Prof. em. Dr. Dr. h.c. mult. K. Meßmer, Prof. Dr. J. Jähne, Prof. Dr. P. Neuhaus Kapitel V-1 Was gibt es Neues bei der Lungen- und Herz-Lungen Transplantation? H. Treede und H. Reichenspurner
5.
Lung and Heart-Lung Transplantation Lung Biology in Health and Disease Edited by Joseph P. Lynch III and David J. Ross Part IV, Chapter 13: Organ Allocation and Donor Availability – The European Experience H. Treede and H. Reichenspurner
4.
Was gibt es Neues in der Chirurgie, Jahresband 2006 (What`s new in Surgery) Berichte zur chirurgischen Fort- und Weiterbildung Editors: Prof. em. Dr. Dr. h.c. mult. K. Meßmer, Prof. Dr. J. Jähne, Prof. Dr. P. Neuhaus Chapter V-1 Was gibt es Neues bei der Lungen- und Herz-Lungen Transplantation? H. Treede und H. Reichenspurner
3.
Was gibt es Neues in der Chirurgie, Jahresband 2005 (What`s new in Surgery) Berichte zur chirurgischen Fort- und Weiterbildung Editors: Prof. em. Dr. Dr. h.c. mult. K. Meßmer, Prof. Dr. J. Jähne, Prof. Dr. P. Neuhaus Chapter V-1 Was gibt es Neues bei der Lungen- und Herz-Lungen Transplantation? H. Treede und H. Reichenspurner
22
Prof. Dr. med. Hendrik Treede
2.
Was gibt es Neues in der Chirurgie, Jahresband 2004 (What`s new in Surgery) Berichte zur chirurgischen Fort- und Weiterbildung Editors: Prof. em. Dr. Dr. h.c. mult. K. Meßmer, Prof. Dr. J. Jähne, Prof. Dr. P. Neuhaus Chapter V-1 Was gibt es Neues bei der Lungen- und Herz-Lungen Transplantation? H. Treede und H. Reichenspurner
1.
Lung Transplantation European Respiratory Monograph, Volume 8, Monograph 26, September 2003 Edited by: J. Boe, M. Estenne, W. Weder Chapter: Operative Techniques H. Treede, H. Reichenspurner, W. Weder
23